Recognizing and preventing drug interactions in older adults with HIV.

Susan M. McLennon, Rachel Smith, Joanne J. Orrick

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Currently, adults older than 50 account for approximately 15% of the total number of acquired immune deficiency syndrome (AIDS) cases. As baby boomers age, the number of older adults infected with the human immunodeficiency virus (HIV) is expected to rise. This expected increase is due, in part, to an increase in the number of individuals newly diagnosed with HIV, and, in part, to improved efficacy of the highly active antiretroviral therapy (HAART) medications used to treat HIV/AIDS. Older individuals who are infected with HIV also are expected to seek treatment for common conditions associated with aging. Thus, a considerable risk for drug interactions between the medications used specifically for HIV treatment and those used for other conditions exists. This article is intended as a guide for gerontological nurses facing these complexities. It includes reviews of the goals of HAART therapy and of the mechanisms of drug interactions, as well as detailed discussions related to the effects of HAART and their potential interactions with medications used to treat conditions commonly found in aging populations.

Original languageEnglish (US)
Pages (from-to)5-12
Number of pages8
JournalJournal of Gerontological Nursing
Volume29
Issue number4
StatePublished - Apr 2003
Externally publishedYes

Fingerprint

Drug Interactions
HIV
Highly Active Antiretroviral Therapy
Acquired Immunodeficiency Syndrome
Therapeutics
Nurses
Population

ASJC Scopus subject areas

  • Gerontology

Cite this

Recognizing and preventing drug interactions in older adults with HIV. / McLennon, Susan M.; Smith, Rachel; Orrick, Joanne J.

In: Journal of Gerontological Nursing, Vol. 29, No. 4, 04.2003, p. 5-12.

Research output: Contribution to journalArticle

McLennon, SM, Smith, R & Orrick, JJ 2003, 'Recognizing and preventing drug interactions in older adults with HIV.', Journal of Gerontological Nursing, vol. 29, no. 4, pp. 5-12.
McLennon, Susan M. ; Smith, Rachel ; Orrick, Joanne J. / Recognizing and preventing drug interactions in older adults with HIV. In: Journal of Gerontological Nursing. 2003 ; Vol. 29, No. 4. pp. 5-12.
@article{f3488a4676784e24947194093d57163e,
title = "Recognizing and preventing drug interactions in older adults with HIV.",
abstract = "Currently, adults older than 50 account for approximately 15{\%} of the total number of acquired immune deficiency syndrome (AIDS) cases. As baby boomers age, the number of older adults infected with the human immunodeficiency virus (HIV) is expected to rise. This expected increase is due, in part, to an increase in the number of individuals newly diagnosed with HIV, and, in part, to improved efficacy of the highly active antiretroviral therapy (HAART) medications used to treat HIV/AIDS. Older individuals who are infected with HIV also are expected to seek treatment for common conditions associated with aging. Thus, a considerable risk for drug interactions between the medications used specifically for HIV treatment and those used for other conditions exists. This article is intended as a guide for gerontological nurses facing these complexities. It includes reviews of the goals of HAART therapy and of the mechanisms of drug interactions, as well as detailed discussions related to the effects of HAART and their potential interactions with medications used to treat conditions commonly found in aging populations.",
author = "McLennon, {Susan M.} and Rachel Smith and Orrick, {Joanne J.}",
year = "2003",
month = "4",
language = "English (US)",
volume = "29",
pages = "5--12",
journal = "Journal of Gerontological Nursing",
issn = "0098-9134",
publisher = "Slack Incorporated",
number = "4",

}

TY - JOUR

T1 - Recognizing and preventing drug interactions in older adults with HIV.

AU - McLennon, Susan M.

AU - Smith, Rachel

AU - Orrick, Joanne J.

PY - 2003/4

Y1 - 2003/4

N2 - Currently, adults older than 50 account for approximately 15% of the total number of acquired immune deficiency syndrome (AIDS) cases. As baby boomers age, the number of older adults infected with the human immunodeficiency virus (HIV) is expected to rise. This expected increase is due, in part, to an increase in the number of individuals newly diagnosed with HIV, and, in part, to improved efficacy of the highly active antiretroviral therapy (HAART) medications used to treat HIV/AIDS. Older individuals who are infected with HIV also are expected to seek treatment for common conditions associated with aging. Thus, a considerable risk for drug interactions between the medications used specifically for HIV treatment and those used for other conditions exists. This article is intended as a guide for gerontological nurses facing these complexities. It includes reviews of the goals of HAART therapy and of the mechanisms of drug interactions, as well as detailed discussions related to the effects of HAART and their potential interactions with medications used to treat conditions commonly found in aging populations.

AB - Currently, adults older than 50 account for approximately 15% of the total number of acquired immune deficiency syndrome (AIDS) cases. As baby boomers age, the number of older adults infected with the human immunodeficiency virus (HIV) is expected to rise. This expected increase is due, in part, to an increase in the number of individuals newly diagnosed with HIV, and, in part, to improved efficacy of the highly active antiretroviral therapy (HAART) medications used to treat HIV/AIDS. Older individuals who are infected with HIV also are expected to seek treatment for common conditions associated with aging. Thus, a considerable risk for drug interactions between the medications used specifically for HIV treatment and those used for other conditions exists. This article is intended as a guide for gerontological nurses facing these complexities. It includes reviews of the goals of HAART therapy and of the mechanisms of drug interactions, as well as detailed discussions related to the effects of HAART and their potential interactions with medications used to treat conditions commonly found in aging populations.

UR - http://www.scopus.com/inward/record.url?scp=0038362498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038362498&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 5

EP - 12

JO - Journal of Gerontological Nursing

JF - Journal of Gerontological Nursing

SN - 0098-9134

IS - 4

ER -